EDGAR Filing Documents for 0001477932-20-007184

Form 8-K - Current report:

SEC Accession No. 0001477932-20-007184

Filing Date

2020-12-10

Accepted

2020-12-09 21:00:08

Documents

Period of Report

2020-12-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ipix_8k.htm	8-K	28065
2	CERTIFICATE OF DESIGNATION	ipix_ex31.htm	EX-3.1	152220
3	FORM OF WARRANT	ipix_ex41.htm	EX-4.1	72969
4	OPINION OF GARY R. HENRIE, ESQ.	ipix_ex51.htm	EX-5.1	13193
5	OPINION OF HOGAN LOVELLS US LLP	ipix_ex52.htm	EX-5.2	10280
6	SECURITIES PURCHASE AGREEMENT	ipix_ex101.htm	EX-10.1	245278
7		ipix_ex52img1.jpg	GRAPHIC	3279
	Complete submission text file	0001477932-20-007184.txt		528031

Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880

Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125

Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 201379203
SIC: 2834 Pharmaceutical Preparations